EURACTIV PR

An easy way of publishing your relevant EU press releases.

Medicines for Europe

Press Releases of this organisation

TITLEsort descending ORGANISATION DATE TOPIC
Now or never: Europe must seize the Pharma Legislation opportunity to ensure patient access to continuous innovation for existing medicines Medicines for Europe 07 Nov 2023 Health & Consumers
Now or never: pragmatism & ambition needed in EU pharma strategy to deliver on Europe’s medicines manufacturing Medicines for Europe 07 Oct 2020 Health & Consumers
Off patent medicines essential for a fairer, healthier, and sustainable Europe says President Christoph Stoller Medicines for Europe 30 Apr 2021 Health & Consumers
Off-patent medicines ready to drive pharma policy reform for equitable access, availability and security of medicines supply Medicines for Europe 15 Jun 2023 Health & Consumers
Oncology, the new era for biosimilar medicines Medicines for Europe 08 Sep 2017 Health & Consumers
Open borders that prioritise essential goods key to medicines supply in Europe Medicines for Europe 02 Jun 2021 Health & Consumers
Orphan and paediatric reform should strive to improve access to medicine for rare disease patients and children Medicines for Europe 30 Jul 2021 Health & Consumers
Parliament’s Health Committee (ENVI) introduces constructive amendments to SPC Manufacturing waiver vote in its official opinion to the Parliament’s Legal Committee (JURI). Medicines for Europe 28 Nov 2018 Health & Consumers
Parliament’s Trade Committee votes for jobs and access to medicines with a comprehensive SPC Manufacturing Waiver! Medicines for Europe 04 Dec 2018 Health & Consumers
Patients should benefit from greater access under new patent package proposals Medicines for Europe 28 Apr 2023 Health & Consumers
Pharmaceutical legislation reforms must support equitable access to medicine in Central and Eastern Europe and security of medicines supplies Medicines for Europe 17 Nov 2022 Health & Consumers
Proposals on wastewater treatment will jeopardise patient access to medicines without helping green transition Medicines for Europe 27 Oct 2022 Health & Consumers
Protecting health: Active generic and biosimilar policies central to EU pharmaceutical strategy Medicines for Europe 03 Mar 2020 Health & Consumers
Reaction to EU Pharmaceutical legislation: Timely and equitable access for patients and security of supply essential for reform Medicines for Europe 27 Apr 2023 Health & Consumers
Ready to drive access to medicines Medicines for Europe 24 Jul 2019 Health & Consumers
Regulatory reforms critical to improve patient access to medicines Medicines for Europe 24 Jan 2022 Health & Consumers
Report identifies 9 key ingredients to improve access to medicines in the hospital setting Medicines for Europe 08 Oct 2019 Health & Consumers
Report shows life sciences industry alliance is taking action to curb antimicrobial resistance, with more to come Medicines for Europe 18 Jan 2018 Health & Consumers, InfoSociety
Repurposing: a golden opportunity for patient centric health investment in Europe Medicines for Europe 06 Apr 2022 Health & Consumers
Risk that European Council will “neuter” SPC manufacturing waiver and give foreign (non-EU) manufacturers strong advantage over EU-based manufacturers Medicines for Europe 12 Oct 2018 Health & Consumers
Smart Pharmacovigilance Essential for Patient Safety Medicines for Europe 29 Jan 2020 Health & Consumers
Smart policies will encourage more critical medicines manufacturing in Europe Medicines for Europe 26 Feb 2021 Health & Consumers
Smart reform of EU pharma and IP legislation key to boosting access to essential medicines Medicines for Europe 30 Jun 2022 Health & Consumers
Smarter use of generic, biosimilar and value added medicines will ensure equitable access to cancer care Medicines for Europe 04 Feb 2021 Health & Consumers
SPC manufacturing waiver cannot be derailed by foreign vested interests Medicines for Europe 07 Feb 2019 Health & Consumers
SPC manufacturing waiver moves a step closer as influential European Parliament ENVI Committee supports reform Medicines for Europe 18 Sep 2018 Health & Consumers
SPC manufacturing waiver, Competition policy, Brexit, pharma incentives European Patent Office take centre stage at 14th Legal Affairs Conference Medicines for Europe 25 Apr 2018 Health & Consumers
Stronger mandate for European Medicines Agency should prioritise patient access to medicines Medicines for Europe 24 Jan 2022 Health & Consumers
Supply chain commitment to tackling problem of medicine shortages Medicines for Europe 02 Mar 2018 Health & Consumers
The EU must stop the offshoring of essential medicines manufacturing investments: ambitious, open and coherent policies must support competitive, robust and sustainable production of APIs and medicines Medicines for Europe 23 Nov 2021 Global Europe

Pages

Jobs

European Emergency Number Association
Communications and Events Intern
Migration Policy Group
Communications Manager
European Digital Rights AISBL
Senior Policy Advisor
Friedrich-Ebert-Stiftung EU Office
Kommunikationspraktikum
European Digital Rights AISBL
Policy Advisor
APRE - Italian Agency for the Promotion of European Research
Project Manager - Horizon Europe
EuropeActive (European Register of Exercise Professionals)
EREPS Administrator/Coordinator